LYON, France , March 22, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its advancements in High Intensity Focused Ultrasound (HIFU) were highlighted at the International Symposium on Therapeutic Ultrasound (ISTU 2016), which
LYON, France , March 17, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that its HIFU and lithotripsy devices were highlighted at the European Association of Urology (EAU) 2016 Annual Congress held in Munich, Germany , on March
LYON, France , March 10, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Sylvester Comprehensive Cancer Center at the University of Miami is the first site in the U.S. to be fully certified in the use of Ablatherm Robotic HIFU.
LYON, France , Jan. 25, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at Sylvester Comprehensive Cancer Center , Miami , using FDA approved Ablatherm Robotic HIFU.
LYON, France , Jan. 06, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that its Japanese subsidiary, Edap Technomed Japan, has secured Japanese PMDA approval for the Quanta Litho Laser.
LYON, France , Dec. 11, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Russia's Federal Service for Surveillance in Healthcare (Roszdravnadzor) has approved Focal One for sale in Russia .